View Author
scopus: 35322170100

Kam, B.L.

(Boen Kam)


patient tumor treatment therapy somatostatin study 177 lu-octreotate receptor response neuroendocrine disease lu-octreotate analog effect imaging liver cancer neuroendocrine tumors peptide month result survival radionuclide uptake carcinoid gepnet cycle radiolabeled metastase lesion group kwekkeboom lu-dota radiolabeled somatostatin analogs octreotide phase signi table grade follow-up combination scintigraphy toxicity kidney metastatic analogue side effects bone lesions medicine trial krenning ep phase ii study bakker wh oncol in-dtpa bone metastases liver metastases krenning journal administration signi ficantly 90 y-dotatoc factor y-dotatoc remission tumours 177 lu-dotatate progression jong m capecitabine gastroenteropancreatic neuroendocrine tumors oncology af finity outcome pancreatic treatment outcome 177 lu-octreotate therapy y-dota somatostatin analogs comparison




10 Most Recent Publications

Peptide receptor radionuclide therapy (PRRT) for GEP-NETs (Article)
Bergsma, H. Vliet, E.I. van Teunissen, J.J.M. Kam, B.L. Herder, W.W. de Peeters, R.P. Krenning, E.P. Kwekkeboom, D.
2012-12-01
Tumor response assessment to treatment with [ 177Lu-DOTA 0,Tyr 3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors: Differential response of bone versus soft-tissue lesions (Article)
Vliet, E.I. van Hermans, J.J. Ridder, M.A.J. de Teunissen, J.J.M. Kam, B.L. Krijger, R.R. de Krenning, E.P. Kwekkeboom, D.
2012-09-01
Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy (Article)
Vliet, E.I. van Teunissen, J.J.M. Kam, B.L. Jong, M. de Krenning, E.P. Kwekkeboom, D.
2012-01-10
Quality of life in 265 patients with gastroenteropancreatic or bronchial neuroendocrine tumors treated with [ 177Lu-DOTA 0,Tyr 3]octreotate (Article)
Khan, S. Krenning, E.P. Essen, M. van Kam, B.L. Teunissen, J.J.M. Kwekkeboom, D.J.
2011-09-01
Preclinical and Clinical Studies of Peptide Receptor Radionuclide Therapy (Article)
Pool, S.E. Krenning, E.P. Koning, G.A. Eijck, C.H.J. van Teunissen, J.J.M. Kam, B.L. Valkema, R. Kwekkeboom, D. Jong, M. de
2010-05-01
Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors (Article)
Kwekkeboom, D.J. Kam, B.L. Essen, M. van Teunissen, J.J.M. Eijck, C.H.J. van Valkema, R. Jong, M. de Herder, W.W. de Krenning, E.P.
2010-03-01
Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors (Article)
Kwekkeboom, D. Herder, W.W. de Eijck, C.H.J. van Kam, B.L. Essen, M. van Teunissen, J.J.M. Krenning, E.P.
2010-03-01
Salvage therapy with177Lu-octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumors (Article)
Essen, M. van Krenning, E.P. Kam, B.L. Herder, W.W. de Feelders, R.A. Kwekkeboom, D.
2010-03-01
Peptide-receptor radionuclide therapy for endocrine tumors (Article)
Essen, M. van Krenning, E.P. Kam, B.L. Jong, M. de Valkema, R. Kwekkeboom, D.
2009-07-01
Treatment with the radiolabeled somatostatin analog [177Lu- DOTA0,Tyr3]octreotate: Toxicity, efficacy, and survival (Article)
Kwekkeboom, D. Herder, W.W. de Kam, B.L. Eijck, C.H.J. van Essen, M. van Kooij, P.P.M. Feelders, R.A. Aken, M.O. van Krenning, E.P.
2008-09-22
  • rss icon RSS Publication Feed
  • foaf icon FOAF Profile